Supplementary Appendix from Nivolumab in Patients with Advanced Platinum-resistant Urothelial Carcinoma: Efficacy, Safety, and Biomarker Analyses with Extended Follow-up from CheckMate 275

Abstract

This appendix includes all supplemental tables and figures referenced in the article.